CompanyGraph
At a glance
- Depends onDownstream position: depends on 11 industries, supplies 6
- ScaleMarket cap is $1.86B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.94: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.94%Below 5Y avg (1.14%)
Annual Rate
CNY 0.10Paid unknown
Payout Ratio
34.3%Sustainable
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
12.55BCNY1.86B · vs all stocks (USD)
Trailing P/E
36.59xRevenue (TTM)
5.06BCNY750.67M · vs all stocks (USD)
Profit Margin
7.03%Beta
0.4640xvs all stocks
52-Week Change
-35.86%vs all stocks
Forward Annual Dividend Yield
0.94%vs all stocks
Market Capitalization
12.55BCNY1.86B · vs all stocks (USD)
Enterprise Value
14.40BCNY2.14B · vs all stocks (USD)
Trailing P/E
36.59xForward P/E
17.39xPrice to Sales (TTM)
2.55xPrice to Book (MRQ)
1.45xEnterprise to Revenue
2.85xEnterprise to EBITDA
19.34xGross Margin
45.83%Profit Margin
7.03%Operating Margin
11.83%Return on Assets (TTM)
2.03%Return on Equity (TTM)
3.82%Revenue (TTM)
5.06BCNY750.67M · vs all stocks (USD)
Revenue per Share (TTM)
4.16CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-5.40%Gross Profit (TTM)
2.34BCNY346.48M · vs all stocks (USD)
EBITDA (TTM)
584.88MCNY86.74M · vs all stocks (USD)
Net Income (TTM)
355.69MCNY52.75M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-30.30%Operating Cash Flow (TTM)
560.87MCNY83.18M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-169.13MCNY-25.08M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1000CNYUpdated Aug 19, 2026Forward Annual Dividend Yield
0.94%vs all stocks
Trailing Annual Dividend Rate
0.1000CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.94%vs all stocks
5-Year Average Dividend Yield
1.14%vs all stocks
Payout Ratio
34.26%Minority Interest (Equity)
-123.55MCNYFY2025 · Dec 31, 2025Revenue
5.13BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.73BCNYFY2025 · Dec 31, 2025Gross Profit
2.41BCNYFY2025 · Dec 31, 2025Operating Income
577.24MCNY85.61M · vs all stocks (USD)
Pre-tax Income
423.70MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.25MCNYFY2025 · Dec 31, 2025Net Income
373.45MCNYFY2025 · Dec 31, 2025EBIT
476.74MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
894.61MCNYFY2025 · Dec 31, 2025Research & Development
291.37MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
1.09BCNYFY2025 · Dec 31, 2025Other Operating Expenses
49.57MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
12.06MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
53.04MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.22BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.22BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
373.45MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
28.57MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
109.00MCNYFY2025 · Dec 31, 2025Free Cash Flow
-425.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
663.77MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
373.45MCNYFY2025 · Dec 31, 2025Other Non-cash Items
66.55MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-109.04MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-221.96MCNYFY2025 · Dec 31, 2025Capital Expenditures
-534.82MCNYFY2025 · Dec 31, 2025Sale of Investments
80.72MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-454.09MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
1.86BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.78BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-171.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
-23.46MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-114.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.22BSharesUpdated Aug 19, 2026Float Shares
596.64MSharesUpdated Aug 19, 2026% Held by Insiders
44.01%vs all stocks
% Held by Institutions
6.01%vs all stocks
Total Cash (MRQ)
751.21MCNY111.40M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.6170CNYUpdated Aug 19, 2026Total Debt (MRQ)
2.38BCNY352.23M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2711xCurrent Ratio (MRQ)
1.34xBook Value per Share (MRQ)
7.31CNYUpdated Aug 19, 2026Total Assets
12.85BCNY1.90B · vs all stocks (USD)
Total Current Assets
3.92BCNYFY2025 · Dec 31, 2025Total Liabilities
4.13BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.92BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.10BCNYFY2025 · Dec 31, 2025Total Current Liabilities
3.03BCNYFY2025 · Dec 31, 2025Cash
663.76MCNYFY2025 · Dec 31, 2025Cash Equivalents
69.20MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
732.97MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.40BCNYFY2025 · Dec 31, 2025Inventory
1.26BCNYFY2025 · Dec 31, 2025Accounts Payable
873.39MCNYFY2025 · Dec 31, 2025Short-term Debt
1.46BCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.18MCNYFY2025 · Dec 31, 2025Long-term Debt
897.83MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
2.73MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.04BCNYFY2025 · Dec 31, 2025Retained Earnings
4.75BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.71BCNY1.29B · vs all stocks (USD)
52-Week Low
9.07CNYUpdated Aug 19, 202652-Week High
16.66CNYUpdated Aug 19, 202652-Week Change
-35.86%vs all stocks
Beta
0.4640xvs all stocks
50-Day MA
10.07CNYUpdated Aug 19, 2026200-Day MA
11.68CNYUpdated Aug 19, 2026Avg 10-Day Volume
15.73MSharesUpdated Aug 19, 2026Avg 30-Day Volume
16.44MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2900CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.46Profit Margin: 0.07
Financial Health
Altman Z-Score 2.94: safe zoneNotable
Altman Z-Score: 2.94
Supply Chain
Downstream position: depends on 11 industries, supplies 6Notable
Outgoing: 6.00Incoming: 11.00
High connectivity hub: 17 industry connectionsNotable
Total Connections: 17.00
Scale
Market cap is $1.86B, above the global median of $1.15BNotable
Market cap (USD): 1,861,631,503.899Global Median: 1,146,734,693.424
Revenue is $750.67M, above the global median of $520.53MNotable
Revenue (USD): 750,670,928.947Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Guobang Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jafron Biomedical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zenas BioPharma, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
UFP Technologies Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Jingfeng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Mirxes Holding Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cohance Lifesciences Limited
Tier 1ProductionApproval-Gated PipelineRule
Ascletis Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vazyme Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Novocure Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow